LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
116.40
+11.20 (10.65%)
Aug 20, 2026, 4:09 PM HKT
| Market Cap | 8.64B |
| Revenue (ttm) | n/a |
| Net Income | -195.39M |
| EPS | -3.45 |
| Shares Out | 74.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 63,400 |
| Open | 106.10 |
| Previous Close | 105.20 |
| Day's Range | 104.10 - 119.30 |
| 52-Week Range | 72.65 - 165.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |